Lyme disease from an ophthalmological point of view;La maladie de Lyme du point de vue de l'ophtalmologue

Journal Francais d'Ophtalmologie

Volumn 28, Issue 2, 2005, Pages 218-223

  Kadz, B ^a   Putteman, A ^a   Verougstraete, C ^a   Caspers, L ^a  

^a SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Borrelia burgdorferi; Immunology; Lyme disease; Ophthalmology

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; DOXYCYCLINE;

ADULT; AGED; BORRELIA BURGDORFERI; CASE REPORT; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; EYE; FEMALE; HEART; HUMAN; IXODES; JOINT; LABORATORY TEST; LYME DISEASE; NERVOUS SYSTEM; REVIEW; SKIN; SYMPTOMATOLOGY; TICK BITE; TICK BORNE DISEASE; WESTERN BLOTTING;

EID: 14844302887     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0181-5512(05)81046-0     Document Type: Review

References (45)

1. Burgdorfer W. Lyme borreliosis: ten years after discovery of the etiologic agent, Borrelia burgdorferi. Infection, 1991;19:257-62.
2. Bigaignon G, Van Bambeke F, Ninane J. La maladie de Lyme: pour une approche diagnostique et thérapeutique rationnelle. Brochure fondée sur un exposé présenté le 28-11-1996.
3. Piacentino JD, Schwartz BS. Occupational risk of Lyme disease: an epidemiological review. Occup Environ Med, 2002;59:75-84.
4. O'Connel S, Granstrom M, Gray JS, Stanek G. Epidemiology of European Lyme borreliosis. Zentralbl Bakteriol, 1998; 287:229-40.
5. Marques AR. Lyme disease: an update. Curr Allergy Asthma Rep, 2001;1:541-9.
6. Melski JW. Lyme borreliosis. Semin Cutan Med Surg, 2000;19:10-8.
7. Shapiro ED, Gerber MA. Lyme disease. Clin Infect Dis, 2000;31:533-42.
8. Nadelman RB, Wormsr GP. Erythema migrans and early Lyme disease. Am J Med, 1995;98:15S-23S.
9. Huppertz HI, Munchmeier D, Lieb W. Ocular manifestations in children and adolescents with Lyme arthritis. Br J Ophthalmol, 1999;83:1149-52.
10. Colucciello M. Ocular Lyme borreliosis. N Engl J Med, 2001;345:1350-1.
11. Mikkila HO, Seppala IJ, Viljanen MK. The expanding clinical spectrum of ocular lyme borreliosis. Ophthalmology, 2000;107:581-7.
12. Krist D, Wenkel H. Posterior scleritis associated with Borrelia burgdorferi (Lyme disease) infection. Ophthalmology, 2002;109:143-5.
13. Miyashiro MJ, Yee RW, Patel G, Ruiz RS. Lyme disease associated with unilateral interstitial keratitis. Cornea, 1999;18: 115-6.
14. Mikkila H, Seppala I, Leirisalo-Repo M, Immonen I, Karma A. The etiology of uveitis: the role of infections with special reference to Lyme borreliosis. Acta Ophtalmol Scand, 1997;75:716-9.
15. Mikkila H, Seppala I, Leirisalo-Repo M, Karma A. The significance of serum antiborrelia antibodies in the diagnostic work-up uveitis. Eur J Ophthalmol, 1997; 7:251-5.
16. Karma A, Stenborg T, Summanen P, Immonen I, Mikkila H, Seppala I. Long-term follow-up of chronic Lyme neuroretinitis. Retina, 1996;16:505-9.
17. Verougstraete C. White dot syndromes. Bull Soc Belge Ophtalmol, 2000;279:67-78.
18. Morales DS, Siatkowski RM, Howard CW, Warman R. Optic neuritis in children. J Pediatr Ophthalmol Strabismus, 2000;37:254-9.
19. Brazis PW, Lee AG. Optic disk edema with a macular star. Mayo Clin Proc, 1996;71:1162-6.
20. Mastrianni JA, Galetta SL, Raps EC, Liu GT, Volpe NJ. Isolated fascicular abducens nerve palsy and Lyme disease. J Neuroophthalmol, 1994;14:2-5.
21. Donta ST. Late and chronic Lyme disease. Med Clin North Am, 2002;86: 341-9.
22. Sigal LH. Persisiting complaints attributed to chronic Lyme disease:possible mechanisms and implications for management. Am J Med, 1995;99:440.
23. Steere AC, Gross D, Meyer AL, Hubert BT. Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis. Autoimmun, 2001;16:263-8.
24. Gross D, Huber BT, Steere AC. Molecular mimicry and Lyme arthritis. Curr Dir Autoimmun 2001;3:94-111.
25. Guerau-de-Arellano M, Huber BT. Development of autoimmunity in Lyme arthritis. Curr Opin Rheumatol, 2002;14: 388-93.
26. Limbach FX, Jaulhac B, Puechal X, Monteil H, Kuntz JL, Piemont Y, Sibilia J. Treatment resistant Lyme arthritis caused by Borrelia garinii. Ann Rheum Dis, 2001; 60:284-6.
27. Lane RS, Lennette ET, Madigan JE. Interlaboratory and intralaboratory comparisons of indirect immunofluorescence assays for serodiagnosis of Lyme disease. J Clin Microbiol, 1990;28:1774-9.
28. Magnarelli LA. Current status of laboratory diagnosis for Lyme disease. Am J Med, 1995;98:10S-12S.
29. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis, 1993;168:392-400.
30. Aguero-Rosenfeld ME, Nowakowski J, Bittker S, Cooper D, Nadelman RB et al. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol, 1996;34:1-9.
31. Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly MG. Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med, 1989;320:1279-80.
32. Hilton E, Tramontane A, Devoti J, Sood SK. Temporal study of immunoglobin M seroreactivity to Borrelia burgdorferi in patients treated for Lyme borreliosis. J Clin Microbiol, 1997;35:774-6.
33. Preac-Mursic V, Pfister HW, Spiegel H, Burk R, Wilske B, Reinhardt S et al. First isolation of Borrelia burgdorferi from an iris biopsy. J Clin Neuroophtalmol, 1993;13:155-61.
34. Quessada T, Martial-Convert F, Arnaud S, Leudet De La Vallee H, Gilot B et al. Prevalence of Borrelia burgdorferi species and identification of Borrelia valaisiana in questing Ixodes ricinus in the Lyon region of France as determined by Polymerase Chain Reaction-Restriction Fragment Length Polymorphism. Eur J Clin Microbiol Infect Dis, 2003;22:165-73.
35. Schmidt BL. PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev, 1997;10:185-201.
36. Van Dam AP. Recent advances in the diagnosis of Lyme disease. Expert Rev Mol Diagn, 2001;1:413-27.
37. Wormser G, Nadelman R, Dattwyler R. Practice Guidelines for the treatment of Lyme Disease. Clin Infect Dis, 1999; 31:S1-14.
38. Steere AC. Duration of antibiotic therapy for lyme disease. Ann Intern Med 2003;138:761-2.
39. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med, 1991;324: 1137.
40. Gayle A, Ringdahl E. Tick-borne diseases. Am Fam Physician, 2001;64:461-6.
41. Krause PJ, Mckay K, Thompson CA, Sikand VK, Lentz R, Lepore T et al. Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlic and Lyme disease. Clin Infect Dis, 2002;34:1184-91.
42. Sigal LH. Lyme disease: a review of aspects of its immunology and immunopathogenesis. Annu Rev Immunol, 1997;15:63-92.
43. Sigal LH, Tatum AH. Lyme disease patients' serum contains igM antibodies to Borrelia burgdorferi that cross-react neuronal antigens. Neurology, 1998;38: 1439-42.
44. Hemmer B, Gran B, Zhao Y, Marques A, Pascal J, Tzou A et al. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat Med, 1999;5:1346-7.
45. Craft JE, Fischer DK, Shimamoto GT, Sterre AC et al. Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness. J Clin Invest, 1986;78:934-9.